Aloe vera-loaded natural rubber latex dressing as a potential complementary treatment for psoriasis.

Aloe vera Complementary treatment Natural rubber latex Occlusive dressing Psoriasis

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Jul 2023
Historique:
received: 03 02 2023
revised: 02 05 2023
accepted: 04 05 2023
medline: 19 6 2023
pubmed: 13 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

Psoriasis is a disease that causes keratinocytes to proliferate ten times faster than normal, resulting in chronic inflammation and immune cell infiltration in the skin. Aloe vera (A. vera) creams have been used topically for treating psoriasis because they contain several antioxidant species; however, they have several limitations. Natural rubber latex (NRL) has been used as occlusive dressings to promote wound healing by stimulating cell proliferation, neoangiogenesis, and extracellular matrix formation. In this work, we developed a new A. vera-releasing NRL dressing by a solvent casting method to load A. vera into NRL. FTIR and rheological analyzes revealed no covalent interactions between A. vera and NRL in the dressing. We observed that 58.8 % of the loaded A. vera, present on the surface and inside the dressing, was released after 4 days. Biocompatibility and hemocompatibility were validated in vitro using human dermal fibroblasts and sheep blood, respectively. We observed that ~70 % of the free antioxidant properties of A. vera were preserved, and the total phenolic content was 2.31-fold higher than NRL alone. In summary, we combined the antipsoriatic properties of A. vera with the healing activity of NRL to generate a novel occlusive dressing that may be indicated for the management and/or treatment of psoriasis symptoms simply and economically.

Identifiants

pubmed: 37172697
pii: S0141-8130(23)01673-2
doi: 10.1016/j.ijbiomac.2023.124779
pii:
doi:

Substances chimiques

Rubber 9006-04-6
Latex 0
Antioxidants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124779

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rondinelli Donizetti Herculano (RD)

São Paulo State University (UNESP), Bioengineering & Biomaterials Group, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil; Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; Autonomy Research Center for STEAHM (ARCS), California State University, Northridge, CA 91324, USA. Electronic address: rondinelli.herculano@unesp.br.

Thainá Oliveira Dos Santos (TO)

São Paulo State University (UNESP), Bioengineering & Biomaterials Group, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

Natan Roberto de Barros (NR)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Giovana Sant'Ana Pegorin Brasil (GS)

São Paulo State University (UNESP), Bioengineering & Biomaterials Group, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil; São Paulo State University (UNESP), Post-Graduate Program in Biotechnology, Institute of Chemistry, 14800-903 Araraquara, SP, Brazil.

Mateus Scontri (M)

São Paulo State University (UNESP), Bioengineering & Biomaterials Group, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

Bruna Gregatti Carvalho (BG)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; University of Campinas (UNICAMP), Department of Materials and Bioprocesses Engineering, School of Chemical Engineering, 13083-852 Campinas, SP, Brazil.

Marvin Mecwan (M)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Neda Farhadi (N)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Satoru Kawakita (S)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Caio Humberto Perego (CH)

São Paulo State University (UNESP), Pharmacognosy Laboratory, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

Flávio Alexandre Carvalho (FA)

São Paulo State University (UNESP), Pharmacognosy Laboratory, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

André Gonzaga Dos Santos (AG)

São Paulo State University (UNESP), Pharmacognosy Laboratory, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

Nayrim Brizuela Guerra (NB)

Area of Exact Sciences and Engineering, University of Caxias do Sul (UCS), Caxias do Sul, RS, Brazil.

Juliana Ferreira Floriano (JF)

São Paulo State University (UNESP), Bioengineering & Biomaterials Group, School of Pharmaceutical Sciences, 14800-903 Araraquara, SP, Brazil.

Cassamo Ussemane Mussagy (CU)

Escuela de Agronomía, Facultad de Ciencias Agronómicas y de los Alimentos, Pontificia Universidad Católica de Valparaíso, Chile.

Zuzana Tirpáková (Z)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; The University of Veterinary Medicine and Pharmacy in Košice, Komenského, 73041 81 Košice, Slovak Republic.

Danial Khorsandi (D)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Arne Peirsman (A)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; Plastic, Reconstructive and Aesthetic Surgery University Hospital Ghent, Ghent, Belgium.

Huu Tuan Nguyen (HT)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Alejandro Gomez (A)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; Autonomy Research Center for STEAHM (ARCS), California State University, Northridge, CA 91324, USA.

Kalpana Mandal (K)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Ricardo José de Mendonça (RJ)

Department of Biochemistry, Pharmacology and Physiology, Federal University of Triangulo Mineiro (UFTM), Uberaba, MG, Brazil.

Bingbing Li (B)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA; Autonomy Research Center for STEAHM (ARCS), California State University, Northridge, CA 91324, USA.

Mehmet Remzi Dokmeci (MR)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA.

Vadim Jucaud (V)

Terasaki Institute for Biomedical Innovation (TIBI), 11507 W Olympic Blvd, Los Angeles, USA. Electronic address: vjucaud@terasaki.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH